Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1339, 2002-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Arya Arash Haghjoo Majid Sadr-Ameli Mohammad
Cardiovascular Drugs and Therapy, Vol. 19, Iss. 3, 2005-05 ,pp. :
Natalizumab in MS well tolerated
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
NSAIDs increase CV risk in coronary artery disease
Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. :
Candesartan CREATEs promise in coronary artery disease
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :
Celecoxib: beneficial effects in coronary artery disease
Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. :